C
China Shineway Pharmaceutical Group Ltd
HKEX:2877
China Shineway Pharmaceutical Group Ltd
HKEX:2877
Price:
8.76
HKD
1.39%
Market Closed
Market Cap:
HK$7.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
CN |
|
Fosterville South Exploration Ltd
XTSX:FSX
|
CA |
|
R
|
Raito Kogyo Co Ltd
TSE:1926
|
JP |
|
R
|
Ruitai Materials Technology Co Ltd
SZSE:002066
|
CN |
|
G
|
Guangdong Hongjing Optoelectronic Technology Inc
SZSE:301479
|
CN |
|
S
|
Shen You Holdings Ltd
HKEX:8377
|
HK |
|
Toda Corp
TSE:1860
|
JP |
|
Zhejiang Shaoxing RuiFeng Rural Commercial Bank Co Ltd
SSE:601528
|
CN |
|
S
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd
SSE:600648
|
CN |
|
Nippon Concrete Industries Co Ltd
TSE:5269
|
JP |
|
China Merchants Port Holdings Co Ltd
HKEX:144
|
HK |
|
Beibu Gulf Port Co Ltd
SZSE:000582
|
CN |
|
BRB-Banco de Brasilia SA
BOVESPA:BSLI4
|
BR |
|
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
US |
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
SSE:601869
|
CN |
|
B
|
Bubang Co Ltd
KOSDAQ:014470
|
KR |
|
S
|
Smart Good Things Holding SA
PAR:MLSGT
|
FR |
|
Mukta Arts Ltd
NSE:MUKTAARTS
|
IN |
|
Corestate Capital Holding SA
XETRA:CCAP
|
LU |
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
KR |
|
Allegiant Travel Co
NASDAQ:ALGT
|
US |
|
M
|
Miyaji Engineering Group Inc
TSE:3431
|
JP |
|
K
|
Keck Seng Investments Hong Kong Ltd
HKEX:184
|
HK |
|
Offerpad Solutions Inc
NYSE:OPAD
|
US |
Relative Value
The Relative Value of one China Shineway Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 8.76 HKD, China Shineway Pharmaceutical Group Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Shineway Pharmaceutical Group Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
China Shineway Pharmaceutical Group Ltd Competitors
China Shineway Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China Shineway Pharmaceutical Group Ltd
HKEX:2877
|
7.1B HKD | 1.9 | 7.8 | -0.2 | -0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.8 | 27.8 | 15.5 | 21.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
